UnitedHealth Group Incorporated $UNH Shares Purchased by Nwam LLC

Nwam LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 46.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,805 shares of the healthcare conglomerate’s stock after acquiring an additional 1,847 shares during the period. Nwam LLC’s holdings in UnitedHealth Group were worth $2,413,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. PBCay One RSC Ltd purchased a new stake in UnitedHealth Group during the 1st quarter worth about $14,343,000. Lee Johnson Capital Management LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $6,180,000. Vaughan David Investments LLC IL lifted its stake in shares of UnitedHealth Group by 2.7% during the fourth quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate’s stock valued at $49,772,000 after buying an additional 3,934 shares during the period. Kinsale Capital Group Inc. grew its stake in UnitedHealth Group by 13.4% in the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock worth $16,006,000 after acquiring an additional 4,557 shares during the period. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. raised its holdings in UnitedHealth Group by 1,287.2% in the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock valued at $16,241,000 after acquiring an additional 55,695 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on UNH shares. Zacks Research raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. Robert W. Baird raised UnitedHealth Group from an “underperform” rating to a “neutral” rating and raised their price target for the stock from $287.00 to $453.00 in a research note on Thursday, July 16th. TD Cowen upped their price objective on shares of UnitedHealth Group from $337.00 to $430.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a report on Friday, July 17th. Finally, Bank of America reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $456.56.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.19% of the stock is owned by insiders.

UnitedHealth Group Stock Up 1.8%

UNH opened at $396.23 on Wednesday. The company has a market cap of $355.65 billion, a PE ratio of 25.50, a price-to-earnings-growth ratio of 1.47 and a beta of 0.61. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The firm has a 50 day moving average price of $412.68 and a 200 day moving average price of $362.36.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the previous year, the firm earned $4.08 earnings per share. UnitedHealth Group’s revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.